aica ribonucleotide has been researched along with Uveal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Moujahed, A; Brodowska, K; Gragoudas, E; Ksander, BR; Marmalidou, A; Miller, JW; Nicolaou, F; Papakostas, TD; Vavvas, DG | 1 |
1 other study(ies) available for aica ribonucleotide and Uveal Neoplasms
Article | Year |
---|---|
Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
Topics: Aminoimidazole Carboxamide; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Phosphotransferases (Phosphate Group Acceptor); Real-Time Polymerase Chain Reaction; Ribonucleotides; RNA, Neoplasm; TOR Serine-Threonine Kinases; Uveal Neoplasms | 2014 |